1. AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/P53 and PI3K/AKT pathways
   Longxiang Huang et al, 2022, Frontiers in Pharmacology CrossRef
2. The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy
   Frank P. Vendetti et al, 2023, JCI Insight CrossRef
3. Update on Emerging Therapies for Advanced Colorectal Cancer
   Olatunji B. Alese et al, 2023, American Society of Clinical Oncology Educational Book CrossRef
4. AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells
   Shinnosuke Harata et al, 2023, Oncology Reports CrossRef
5. MFAE: Multilevel Feature Aggregation Enhanced Drug‐Target Affinity Prediction for Drug Repurposing Against Colorectal Cancer
   Guanxing Chen et al, 2024, Advanced Intelligent Systems CrossRef
6. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells
   Zijie Gao et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
7. The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork
   Joanne Saldanha et al, 2023, International Journal of Molecular Sciences CrossRef